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Introduction {#sec1}
============

Hematopoietic stem cell (HSC) transplantation is a curative regenerative therapy for patients with blood-related disorders. More than 50,000 transplants are carried out annually worldwide. For patients without a histo-compatible donor, the lack of matched HSCs is a serious problem. Given that HSCs do not expand in *in vitro* cultures, patient-derived induced pluripotent stem cells (iPSCs) may be an alternative source for the *de novo* production of HSCs. Although it is possible to differentiate iPSCs and to reprogram cells into hematopoietic progenitors, the generation of robust *in vivo* repopulating HSCs *in vitro* has not yet been achieved without genetic manipulation ([@bib14]). Thus, an understanding of the *in vivo* microenvironment in which HSCs are first generated should provide insights into improving such *in vitro* strategies.

HSCs arise in the AGM (aorta-gonad-mesonephros) region ([@bib45]) and other major arteries ([@bib11]) through a transdifferentiation process called endothelial-to-hematopoietic transition (EHT) ([@bib17], [@bib28]). In the mouse embryo, HSCs are generated in a complex and dynamic microenvironment during a short period of developmental time (embryonic day \[E\]10.5--E12.5) ([@bib77]). Tissues ventral to the AGM ([@bib54], [@bib67]), including cells of the sympathetic nervous system ([@bib20]), exert a positive effect on HSC emergence. Moreover, AGM-derived stromal cell lines produce regulators, such as bone morphogenetic protein (BMP) and hedgehog (Hh), that support HSC generation and/or maintenance, as demonstrated by transcriptional profiling and culture approaches ([@bib8], [@bib10], [@bib16], [@bib58]).

Hematopoietic development occurs in at least three distinct waves ([@bib17]), with HSCs made only in the last wave. Macrophages are generated in all three waves, first in the mouse yolk sac (YS) beginning at E7.5 ([@bib53], [@bib69]), then in the second YS wave at E8.25 ([@bib25]) from erythro-myeloid progenitors (EMPs) ([@bib21], [@bib53]), and finally from HSC-derived monocytes. EMPs emigrate to the embryo body, where they give rise to hematopoietic cells found in the embryo prior to HSC emergence at E10.5. Because the three distinct waves of hematopoietic generation temporally overlap, the hematopoietic cells generated in the earlier two waves could be part of the microenvironment that affects the production of HSCs intraembryonically in the third wave ([@bib9], [@bib18], [@bib38], [@bib70]).

Macrophages from the first two waves function developmentally in tissue remodeling ([@bib27], [@bib37], [@bib48]). They infiltrate the limbs, mandibular arches, liver, kidneys, and brain between E9.5 and E10.5 and represent 2%--5% of total cells in these tissues ([@bib57]). In adult tissues, macrophages regulate steady-state hematopoiesis ([@bib26]), hematopoietic cell egress ([@bib29]), and erythrocyte maturation ([@bib41]). They are best known for their innate immune pro- and anti-inflammatory functions in response to trauma, tissue damage, and tissue repair.

Some inflammatory molecules and cells have been implicated in the regulation of hematopoietic development in the embryo ([@bib18], [@bib38], [@bib49], [@bib52]). Interferon-γ (IFN-γ), interleukin-1β (IL-1β), tumor necrosis factor α (TNF-α), and matrix metalloproteases (Mmps) have been shown to enhance hematopoietic output in both zebrafish and mouse embryos, and neutrophils are the cellular effectors in zebrafish embryos. However, the identity of inflammatory cells in the mouse AGM microenvironment that may affect hematopoietic development is unclear. Macrophages are present in both mouse ([@bib57], [@bib75]) and E34-stage human embryos ([@bib70]) along the aorta where HSCs emerge. Here, we examined the innate immune-cell composition of the mouse AGM HSC-generative microenvironment and show that macrophages were the most abundant hematopoietic cell type. We identified a CD206^+^ pro-inflammatory macrophage subset that was highly dynamic and showed that macrophages were a crucial cellular component of the HSC inductive niche.

Results {#sec2}
=======

Macrophages Are the Most Abundant Hematopoietic Cells in the AGM {#sec2.1}
----------------------------------------------------------------

To investigate the cellular composition of the AGM microenvironment, we performed mass cytometry (CyTOF) on mouse E10.5 AGM cells. Cells were stained with metal-conjugated antibodies recognizing CD45 (pan-hematopoietic cell marker), hematopoietic lineage markers, and endothelial markers ([Table S1](#mmc2){ref-type="supplementary-material"}; [Key Resources Table](#sec4.1){ref-type="sec"}). Adult mouse spleen served as control. Concatenated t-distributed stochastic neighbor embedding (tSNE) plots of AGM and spleen cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A) revealed different cluster distributions and frequencies. The AGM contained a few large unique CD45^−^ cell clusters (10, 14, and 18), whereas most spleen cells were CD45^+^ ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Flow cytometry analysis verified that only 0.47% ± 0.1% of AGM cells were CD45^+^ ([Figure S2](#mmc1){ref-type="supplementary-material"}). Hence, CyTOF analysis on unsorted AGM cells was not informative for hematopoietic cell composition.

To more-specifically characterize the AGM hematopoietic composition, CyTOF was performed on CD45^+^ cells sorted from E10 AGM and YS tissues and an adult spleen. Concatenated tSNE plots ([Figure 1](#fig1){ref-type="fig"}A) revealed two major clusters of CD45^+^ AGM cells in common with YS cells. Together, these two clusters represent 83.4% and 81.7% of the AGM and YS CD45^+^ cells, respectively ([Figure 1](#fig1){ref-type="fig"}B). Two other smaller clusters of CD45^+^ cells (14.2% in AGM and 15.2% in YS) were in common between these tissues. In contrast, spleen contained five major CD45^+^ clusters (86.1% of cells) that were different from the clusters in the embryonic tissuesFigure 1CyTOF Analysis of CD45^+^ AGM, Yolk Sac, and Adult Spleen Cells(A) tSNE clusters indicated by color (12 with \>10 cells) of CD45^+^ E10 AGM (top), E10 YS (middle) (n = 31, 31--37 sp) and adult spleen (bottom) cells based on 21 cell-surface markers.(B) Heatmaps of surface-marker expression in CD45^+^ AGM (top), YS (middle), and spleen (bottom) cells with percentages of cells in each tSNE cluster and lineage phenotype: N, neutrophils; M, macrophage and macrophage progenitor; L, lymphocytes and lymphoid progenitors, P, multipotential progenitor.

As shown in the heatmaps ([Figure 1](#fig1){ref-type="fig"}B), the major AGM and YS tSNE clusters corresponded to phenotypic macrophages or macrophage progenitors (M) expressing varying degrees of cluster of differentiation 11b (CD11b); F4/80; CD206; Ly6C; CD16/32; CD64; Mer proto-oncogenetyrosine kinase (MerTK); and Fc fragment of IgE receptor 1α (FcεR1α). The two smaller AGM and YS clusters appeared to be multilineage progenitors (P), as they expressed a combination of additional markers that included CD41, CD11c, B220, CD3, and CD43. Macrophages and macrophage progenitors were only 0.7% of the spleen CD45^+^ population. Instead, both B and T lymphoid cells and lymphoid progenitors (L) made up four of the major populations, as defined by Ly6C, CD41, B220, CD3, and/or CD19 expression. The fifth major spleen CD45^+^ population was composed of neutrophils (N), as defined by Ly6G expression. The AGM contained rare immature neutrophils (N). The AGM and YS contained no or undetectable mature lymphoid or other innate immune cells but had progenitor cells (overlapping with rare tSNE spleen clusters) that appeared to be lineage primed. E10 AGM and YS myeloid cells were separated into two major phenotypic macrophage clusters by CD206 expression: CD11b^+^F4/80^lo^CD206^−^ cells were more frequent than CD11b^+^F4/80^+^CD206^+^ cells. These macrophages and/or macrophage progenitors were the most abundant hematopoietic cell types in the embryonic tissues.

Macrophages Accumulate in the AGM Prior to HSC Production {#sec2.2}
---------------------------------------------------------

The *MacGreen* (*Csf1rGFP*) transgenic mouse model facilitated vital imaging, localization, and isolation of AGM macrophages. Flow cytometry (CD45, CD11b, F4/80, Ly6C, Ly6G, CD3, B220, and MerTK; [Figure S3](#mmc1){ref-type="supplementary-material"}A) revealed that all E10.5 AGM GFP^+^ cells were CD45^+^ and \>95% of them were positive for CD11b, F4/80, and MerTK, common macrophage markers in the adult mouse. \>99% of GFP^+^ cells were negative for CD3 (T lymphocyte), B220 (B lymphocyte), and Ly6G (granulocyte) markers. Morphological examination (nucleus shape, cytoplasm) of Rapid Romanowsky stained cells confirmed that the majority of AGM GFP^+^ cells were macrophages ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Out of 500 cells screened, 74% (371) were fully differentiated macrophages, 23% (115) were progenitors, and only 3% (15) were immature neutrophilic band cells ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Thus, the *MacGreen* reporter defines mainly macrophages in the embryo.

Macrophage appearance in *MacGreen* AGMs (E8.5 to E11.5) was assessed by flow cytometry ([Figures 2](#fig2){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). No GFP^+^ cells were found in the E8.5 AGM and very few were detected at E9. The first AGM GFP^+^ cells appeared at E9.5, and at E10 the percentage increased 5-fold (p \< 0.001) just prior to the appearance of HSCs. GFP^+^ cells continued to significantly increase from E10.5 ([Figure 2](#fig2){ref-type="fig"}A) and, thereafter, may have included some HSC (monocyte)-derived macrophages. Already at E9, most GFP^+^ cells were CD45^+^, but only 20% expressed the mature macrophage markers CD11b and F4/80. However, at E10, 80% of GFP^+^ cells were positive for CD11b and F4/80 ([Figure 2](#fig2){ref-type="fig"}A). These results suggest that GFP^+^ cells enter the AGM as progenitors and later become fully mature macrophages. This was supported by time-course analysis of the YS showing that 30% of GFP^+^ cells present at E8.5 were CD45^+^, but none expressed CD11b or F4/80 ([Figures 2](#fig2){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}B). These were the predominant GFP^+^ population in the YS until E9.5. Thereafter, the percentage of CD11b- and F4/80-expressing cells in the YS GFP^+^CD45^+^ fraction increased to 60%--95%. Together, these data suggest that AGM macrophages are derived from YS progenitors that enter and fully differentiate in the AGM.Figure 2Appearance and Localization of AGM Myeloid Cells(A and B) Flow cytometric analysis of E8.5 to E11.5 *MacGreen* (A) AGM and (B) YS cells. Percentage of GFP^+^ cells (top), CD45^+^ cells in GFP^+^ fraction (middle), and CD11b^+^F4/80^+^ cells in CD45^+^ fraction (bottom). Mean + SEM (n = 3/time, 2--4 AGM, 2--3 YS). ND, not done. One-way Anova with Bonferroni correction.(C) Maximum projection confocal image of whole-mount E10 *MacGreen* embryo showing the trunk. A, aorta; V, vitelline artery. CD31^+^ endothelium, gray; macrophages, green; c-Kit^+^ IAHCs, magenta. Scale bar, 200 μm. High-magnification images of IAHC (right). Scale bars, 20 μm.(D) Immunofluorescence of E10.5 *MacGreen* embryo transverse cryosection (10 μm) through aorta. AGM, aorta-gonad-mesonephros; NT, neural tube; S, somites. Yellow line, spatial boundaries of AGM. CD34^+^ endothelium is in magenta, macrophages in green, and nuclei in blue (DAPI). Scale bar, 100 μm.(E) Total number of macrophages per μm^2^ in non-hematopoietic tissues of trunk (non-AGM) and AGM region. n = 40 (10 random sections, 4 embryos). The data are represented as mean + SEM. One-way Anova with Dunnett post-hoc test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

GFP^+^ macrophages were found in a punctate distribution within *MacGreen* E10.5 immunostained trunk regions ([Figure 2](#fig2){ref-type="fig"}C), consistent with CD45^+^ and F4/80^+^ cell distribution shown previously ([@bib57], [@bib75]). Macrophages were present throughout the trunk and AGM, and single GFP^+^ macrophages were in close contact with aortic endothelial cells and intra-aortic hematopoietic cluster cells (IAHCs; CD31^+^c-Kit^+^) ([Figure 2](#fig2){ref-type="fig"}C, enlargements).

To quantitatively examine macrophage localization within the trunk region, E10.5 *MacGreen* transversal sections (10 μm) were immunostained for CD34 ([Figure 2](#fig2){ref-type="fig"}D). The number of GFP^+^ cells/μm^2^ was assessed in the AGM (with notochord, gut, and mesonephros as the dorsal, ventral, and lateral boundaries, respectively) and non-AGM trunk region. Significantly more macrophages were found in the AGM (near the IAHCs and aorta) than in the rest of the trunk region ([Figure 2](#fig2){ref-type="fig"}E; p \< 0.001), consistent with findings in Zebrafish embryos ([@bib70]).

Cx3cr1 Is Involved in Macrophage Progenitor Recruitment to the AGM {#sec2.3}
------------------------------------------------------------------

Chemokine receptors and chemokines are pivotal in mediating leukocyte recruitment to adult tissues ([@bib23], [@bib40]). To identify what stimuli may attract macrophage progenitors to the AGM, we assessed the expression of chemokine receptors that are commonly found on adult macrophages (Ccr2, Ccr3, Ccr5, Ccr7, Cxcr2, Cxcr4, and Cx3cr1). Flow cytometric analysis of E10 and 10.5 *MacGreen* AGM ([Figures 3](#fig3){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A) and YS ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}B) macrophages (GFP^+^ cells) showed the highest expression of Cx3cr1. The other receptors were low or undetectable at E10. At E10.5, Ccr2 and Cxcr4 expression showed some increase on AGM and YS macrophages, and Ccr3 expression increased on YS macrophages.Figure 3Macrophage Recruitment to the AGM is Cx3cr1 Mediated(A and B) Cytofluorimetric analysis of chemokine receptors on (A) AGM and (B) YS macrophages of E10 and E10.5 *MacGreen* embryos. GeoMean over FMO (fluorescence minus one). Bars represent mean + SEM (n = 3, 2--3 AGM or YS/experiment).(C) Semi-quantitative RT-PCR analysis of *Ccl2*, *Ccl11*, *Ccl3*, *Cxcl12*, and *Cx3cl1* in CD31^+^ cells of E10.5 *MacGreen* AGM. Data are fold-change over the expression in GFP^+^ cells, set as one (horizontal line). Bars represent mean + SEM (n = 3).(D and E) Semi-quantitative RT-PCR analysis of (D) *Cxcl12* and (E) *Cx3cl1* in E10.5 *Ly6A*-*GFP* embryos. Data normalized to CD31^+^ cells. Bars represent mean + SEM (n = 3).(F) Cytofluorimetric percentages of macrophages (CD45^+^c-Kit^−^CD11b^+^F4/80^+^) in AGM (left) and YS (right) of E10.5 *Cx3cr1*^+/+^ wild type, *Cx3cr1*^gfp/+^, and *Cx3cr1*^gfp/gfp^ embryos. Each symbol is an individual embryo. Error bars represent mean + SEM.(G) CFU-C assay showing the number of colonies/AGM in E10.5 *Cx3cr1*^+/+^, *Cx3cr1*^gfp/+^, and *Cx3cr1*^gfp/gfp^ embryos. BFU-E, burst forming unit-erythroid; CFU-G, CFU-granulocyte; CFU-M, CFU-macrophage; CFU-GM, CFU-granulocyte, macrophage; CFU-GEMM, CFU-granulocyte, erythrocyte, macrophage, megakaryocyte. Mean + SEM (n = 4).(C and G) Student's t test; (D--F) one-way Anova with Bonferroni correction. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See [Figure S5](#mmc1){ref-type="supplementary-material"}.

Ligand expression was tested by semi-quantitative RT-PCR (*Ccl2*, *Ccl11*, *Ccl3*, *Cxcl12*, and *Cx3cl1*) on *MacGreen* AGM CD31^+^GFP^−^ cells (endothelial and IAHC) and GFP^+^ macrophages ([Figure 3](#fig3){ref-type="fig"}C). Although *Ccl2*, *Ccl3*, and *Ccl11* transcripts were more abundant in AGM macrophages, *Cxcl12* and *Cx3cl1* were more highly expressed by CD31^+^ AGM cells, suggesting that the elicitation of these chemokines by non-macrophage cell subsets acts to attract macrophages. To examine what CD31^+^ AGM cells expressed *Cxcl12* and *Cx3cl1*, CD31^+^ cells from *Ly6AGFP* AGMs ([@bib12]) were sorted according to GFP and c-Kit expression. This mouse transgenic reporter model allows high enrichment of endothelial (CD31^+^GFP^−^c-Kit^−^), hematopoietic (CD31^+^GFP^−^c-kit^+^), hematopoietic stem and/or progenitor (HS/PC) (CD31^+^GFP^+^c-Kit^+^), and hemogenic endothelial cells (CD31^+^GFP^+^c-Kit^−^) ([@bib63]). Compared to endothelial cells, *Cxcl12* was 1.75-fold higher in hemogenic endothelial cells. Hematopoietic subpopulations ([Figure 3](#fig3){ref-type="fig"}D) showed lower expression. C*x3cl1* expression was 2.5- to 3.2-fold higher in HS/PCs and hemogenic endothelial cells ([Figure 3](#fig3){ref-type="fig"}E) compared to the other cell fractions, suggesting a major involvement of Cx3cr1 in macrophage recruitment to nascent and emerging IAHCs.

To test this, we isolated AGM and YS cells from *Cx3cr1*^gfp/gfp^ mice in which the insertion of the *GFP* gene results in a *Cx3cr1* null deletion ([@bib30]). Flow cytometry analysis showed that the percentage of macrophages (CD45^+^c-Kit^−^CD11b^+^F4/80^+^) in *Cx3cr1*^gfp/gfp^ AGMs was significantly lower than wild type and *Cx3cr1*^gfp/*+*^ AGMs ([Figure 3](#fig3){ref-type="fig"}F, left). In contrast, the percentage of macrophages in the *Cx3cr1*^gfp/gfp^ YS was significantly higher compared to those in wild-type YS ([Figure 3](#fig3){ref-type="fig"}F, right). The inverse correlation of macrophage percentages in the AGM versus YS suggested that the macrophage accumulation in the YS was due to a lack of Cx3cr1-related macrophage recruitment to the AGM.

The colony-forming unit (CFU)-C assay was performed on AGM cells from wild-type, *Cx3cr1*^gfp/+^, and *Cx3cr1*^gfp/gfp^ embryos to examine whether the percentage of macrophages in the AGM affected hematopoietic progenitor cell (HPC) numbers. A significant reduction in colony numbers (total, CFU-GEMM, and CFU-M) was found in *Cx3cr1*^gfp/gfp^ AGMs compared to wild type, and there appeared to be a dosage effect on *Cx3cr1*^gfp/+^ AGM colony output ([Figure 3](#fig3){ref-type="fig"}G). Thus, Cx3cr1-mediated macrophage recruitment to the AGM has a positive influence on AGM HPC output.

AGM-Associated Macrophages Dynamically Interact with Nascent and Emerging IAHCs {#sec2.4}
-------------------------------------------------------------------------------

Since macrophages are motile cells, vital time-lapse microscopy ([@bib6]) was performed on thick embryo sections to examine macrophage dynamics within E10.5 *MacGreen* AGMs ([Figure 4](#fig4){ref-type="fig"}A). GFP^+^ macrophages were found to be adjacent to and/or in direct contact with 28 out of 83 IAHCs (34%) examined (20 thick sections, n = 4). Within 75-min segment, macrophages were found to intravasate (through the aortic wall) to reach c-Kit^+^ cells within the lumen ([Figure 4](#fig4){ref-type="fig"}B; [Video S1](#mmc7){ref-type="supplementary-material"}). Macrophages were observed to interact for ≤3 h and push c-Kit^+^ cells towards the aortic lumen ([Figure 4](#fig4){ref-type="fig"}C; [Video S2](#mmc8){ref-type="supplementary-material"}). Moreover, some macrophages underwent cell division after "sensing" a portion of the aorta and, thereafter, each daughter macrophage moved and interacted with two separate CD31^+^c-Kit^+^ hematopoietic cells ([Figure 4](#fig4){ref-type="fig"}D; [Video S3](#mmc9){ref-type="supplementary-material"}). These data show that highly motile AGM macrophages transiently interact with nascent and emerging IAHCs and suggest that such interactions directly influence HS/PC generation and/or maturation.Figure 4Macrophages Co-localize and Interact with IAHCs(A and B) Immunofluorescence (A) and time-lapse imaging extracted time points (B) of transversal sections (150 μm) of E10.5 *MacGreen* embryos. Macrophages, green; CD31^+^ endothelium, gray; c-Kit^+^ cells, blue. Scale bars, 20 μm.(B--D) Time is indicated at the top of each image. White arrows indicate the macrophages entering the aorta (B) or interacting with IAHCs (A, C, D). See [Videos S1](#mmc7){ref-type="supplementary-material"}, [S2](#mmc8){ref-type="supplementary-material"}, and [S3](#mmc9){ref-type="supplementary-material"}.

Video S1. CSF1R^+^ Embryonic Macrophages Move through the Aortic Wall at E10.5, Related to Figure 4BTime lapse *in vivo* imaging of 150 μm transversal sections of 38 sp *MacGreen* AGM showing a macrophage intravasating into the aorta. The wall of the aorta is defined by CD31 labeling of endothelial cells (red); c-Kit cells are stained in blue and macrophages are displayed in green (endogenous GFP expression). Z-step = 3 μm, 10 min interval between two consecutive scanning. Images acquired on CSU-W1 Spinning Disk confocal (20× objective) and analyzed with Slidebook Full Version.

Video S2. CSF1R^+^ Embryonic Macrophages Interact with Intra-Aortic Clusters in the AGM, Related to Figure 4CTime lapse *in vivo* imaging of 150 μm transversal sections of 37 sp *MacGreen* AGM showing two macrophages pushing an IAHC towards the aorta lumen. The wall of the aorta is defined by CD31 labeling of endothelial cells (red); c-Kit cells are stained in blue and macrophages are displayed in green (endogenous GFP expression). Z-step = 3 μm, 10 min interval between two consecutive scanning. Images acquired on CSU-W1 Spinning Disk confocal (20× objective) and analyzed with Slidebook Full Version.

Video S3. CSF1R^+^ Embryonic Macrophages Undergo Cell Division in the AGM Region, Related to Figure 4DTime lapse *in vivo* imaging of 150 μm transversal sections of 39 sp *MacGreen* AGM showing a macrophage undergoing cell division. The wall of the aorta is defined by CD31 labeling of endothelial cells (red); c-Kit cells are stained in blue, and macrophages are displayed in green (endogenous GFP expression). Z-step = 3 μm, 10 min interval between two consecutive scanning. Images acquired on Andor spinning disk (20× objective) and analyzed with the integrated software.

Hematopoietic Progenitor Cell Numbers Are Proportional to AGM Macrophage Percentages {#sec2.5}
------------------------------------------------------------------------------------

The effect(s) of macrophages on AGM HPC output and function was examined using two macrophage depletion approaches ([Figure 5](#fig5){ref-type="fig"}A). In the first approach, BLZ945, an inhibitor of the colony stimulating factor 1 receptor (CSF1R) was added to E10.5 *MacGreen* AGM explant cultures. The overall viability of AGM explant cells after 72 h was unaffected by a range of BLZ945 concentrations ([Figure 5](#fig5){ref-type="fig"}B). However, a significant (55%--60%) decrease in macrophage percentages was observed in 6.7 μM and 67 μM BLZ945-treated AGM explants ([Figure 5](#fig5){ref-type="fig"}C), as compared to dimethyl sulfoxide (DMSO) control or 0.67 μM BLZ945-treated AGM explants. To test if macrophage depletion affected AGM HPC numbers, the CFU-C assay was performed. The total number of CFU-C and CFU-GEMM (granulocyte, erythrocyte, monocyte, megakaryocyte) per AGM was significantly decreased in 6.7-μM and 67-μM-treated explants compared to DMSO controls ([Figure 5](#fig5){ref-type="fig"}D), thus showing that AGM CFU-C numbers are directly related to the percentage of AGM macrophages.Figure 5AGM HS/PC Are Reduced upon Macrophage Depletion(A) Experimental set-up. CFU-C, colony forming unit in culture; Tx, transplantation. Cytofluorimetric percentages of (B and E) viable cells and (C and F) macrophages in AGM explants treated with BLZ945 (0.67, 6.7, or 67 μM) or clodronate-liposomes compared to controls. Arrow, reduction in macrophage percentages upon treatment. (D and G) CFU-C numbers per AGM explant upon BLZ945 or clodronate-liposome treatment compared to control with percentage reduction shown. BFU-E, burst forming unit-erythroid; CFU-G, colony forming unit-granulocyte; CFU-M, colony forming unit-macrophage; CFU-GM, colony forming unit-granulocyte, macrophage; CFU-GEMM, colony forming unit-granulocyte, erythrocyte, macrophage, megakaryocyte. PBS-L, PBS-liposomes; Clod-L, clodronate-liposomes. *In vivo* transplantation of (H) BLZ945-treated and (I) clodronate-liposome-treated AGM explant cells into irradiated adult Ly5.1 recipients. Chimerism (%CD45.2^+^) in peripheral blood of recipients at 4 and 16 weeks post-transplant. Each symbol = one mouse. Triangles, BLZ945 or Clod-L treated AGMs; circles, controls (n = 3, Student's t test). (B, C, D, F, G) Mean + SEM (n = 4). (H, I) The horizontal lines represent the mean. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See [Figure S6](#mmc1){ref-type="supplementary-material"}.

In the second approach, apoptosis-inducing clodronate-liposomes ([@bib56], [@bib72]) were used to achieve macrophage-specific depletion ([Figure 5](#fig5){ref-type="fig"}A). AGM explants incubated 72 h with clodronate-liposomes showed no change in total AGM-cell viability compared to PBS-liposome-treated explants ([Figure 5](#fig5){ref-type="fig"}E), whereas macrophages (CD45^+^CD11b^+^F4/80^+^) were decreased significantly by \>70% ([Figure 5](#fig5){ref-type="fig"}F). Assessment of the HPC potential of the AGMs after clodronate-liposome treatment demonstrated a significant 43%--45% decrease in the total number of CFU-Cs, with a significant reduction in CFU-M and multipotent CFU-GEMM ([Figure 5](#fig5){ref-type="fig"}G) compared to control. To prove that the reduction of HPC potential was due to the absence of macrophages and not mediated by a direct effect of clodronate-liposomes on committed myeloid progenitors, the lymphoid potential of AGM HPC was assessed. AGM explants were incubated with clodronate or control PBS liposomes for 72 h, and the B lymphoid output was assessed after ten days of co-culture on OP9 cells ([Figure S6](#mmc1){ref-type="supplementary-material"}A). No change in total AGM-cell viability was found ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C), and the percentage of macrophages (CD45^+^CD11b^+^F4/80^+^) was decreased by 60% ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6D) in clodronate-liposome-treated AGMs compared to the control. The percentages of CD45^+^B220^+^ (B cell progenitors) and CD45^+^B220^+^CD19^+^ (mature B cells) populations were also decreased in the clodronate-liposome-treated co-cultures ([Figures S6](#mmc1){ref-type="supplementary-material"}B, S6E, and S6F), demonstrating an effect of macrophage depletion on B lymphoid progenitors. The direct correlation between the percentage of macrophages and the number of HPCs, including multilineage and lymphoid progenitors in the AGM, supports a role for macrophages in promoting HPC generation.

AGM HSC Production Is Impaired in the Absence of Macrophages {#sec2.6}
------------------------------------------------------------

BLZ945-inhibition and clodronate-liposome treatments were performed to test whether macrophages affect the production of AGM HSCs. Cells from BLZ945- or DMSO-treated AGM explants (Ly5.2 embryos; 37-39 sp) were intravenously injected into irradiated Ly5.1 adult mice. When donor-cell chimerism was assessed in the peripheral blood (PB) at 4 and 16 weeks post transplantation ([Figure 5](#fig5){ref-type="fig"}H), only 2 of 8 mice injected with BLZ945-treated AGM explant cells showed any PB donor-cell chimerism. In contrast, almost all (6 out of 8) recipients injected with control cells showed high percentages of donor-derived hematopoietic repopulation.

Similarly, cells from clodronate- and PBS-liposome-treated AGM explants (Ly5.2 embryos; 37-39 sp) were intravenously injected into irradiated Ly5.1 adult mice ([Figure 5](#fig5){ref-type="fig"}I). No donor-cell chimerism was found in the PB of 6 mice injected with clodronate-treated AGM explant cells at 4 and 16 weeks post-transplantation, whereas 4 out of 6 mice were reconstituted with cells from PBS-liposome-treated AGMs. Long-term multilineage engraftment was found in the bone marrow (BM), spleen, lymph node (LN), thymus, and PB of recipients of PBS control AGM cells, whereas no donor engraftment was found in recipients of clodronate-liposome-treated AGM cells (data not shown). Thus, macrophages play a role in the generation and/or maturation of HSCs in the mouse AGM.

CD206 Discriminates AGM-Associated Macrophages from Macrophage Progenitors {#sec2.7}
--------------------------------------------------------------------------

Further characterization of E10.5 AGM macrophages showed they were negative for Flk1 (Vegfr2; [@bib74]), Tie2 (angiopoietin receptor; [@bib22]), and IA/IE (histocompatibility molecule) ([Figure 6](#fig6){ref-type="fig"}A). However, ∼50% of E10.5 AGM macrophages expressed CD206 (mannose receptor). CD206^+^ macrophage percentages increased from E10 to E11 ([Figure 6](#fig6){ref-type="fig"}B). Cytospins of E10.5 *MacGreen* AGMs revealed that CD206^+^ macrophages contain quantitatively more vacuoles than CD206^−^ cells ([Figure 6](#fig6){ref-type="fig"}C), suggesting different maturation or activation states.Figure 6Majority of E10.5 AGM Macrophages are CD206^+^(A) Histograms (white), representative of 4 independent experiments, show percentages of AGM macrophages expressing Flk1, Tie2, IA/IE, and CD206 in E10.5 *MacGreen* embryos. FMO, gray.(B) Time course of %CD206^+^ cells in E10--E11 *MacGreen* AGM. The data are represented as mean + SEM (n = 3).(C) Rapid Romanowsky staining of cytospun E10.5 *MacGreen* (CD45^+^CD11b^+^F4/80^+^GFP^+^CD206^+/−^) macrophages. Left, GFP^+^CD206^−^; right, GFP^+^CD206^+^ cells. Scale bar, 20 μm. Black box separates cells from different slides. Number of vacuoles in CD206^−^GFP^+^ cells (white bars) and CD206^+^GFP^+^ macrophages (gray bars). 100--120 cells/population scored.(D) Schematic of OP9-DL1 co-culture experiments (top). CD206^−^GFP^+^=GFP^+^CD45^+^CD206^−^; CD206^+^GFP^+^=GFP^+^CD45^+^CD206^+^; EC, endothelial cells (CD45^−^CD41^−^CD31^+^). Cell combinations plated on OP9-DL1 are indicated under the graph. Number of CFUs in culture (CFU-C) per 5×10^3^ CD45^+^ cells. BFU-E, burst forming unit-erythroid; CFU-G, colony forming unit-granulocyte; CFU-M, colony forming unit-macrophage; CFU-GM, colony forming unit-granulocyte, macrophage; CFU-GEMM, colony forming unit-granulocyte, erythrocyte, macrophage, megakaryocyte.(E) Total number of CD206^−^GFP^+^ and CD206^+^GFP^+^ cells/μm^2^ in non-hematopoietic trunk region (non-AGM) and AGM. n = 40 (10 random sections, 4 embryos), two-way ANOVA with multiple comparisons corrected by a Tukey's range test, ^∗∗∗^p \< 0.001. The data are represented as mean + SEM.(F) Fluorescent image of a representative E10.5 *MacGreen* transverse section (10 μm) showing an AGM-associated macrophage (AGM-aM) along the aortic wall (left). Scale bar, 100 μm. Boxed area is enlarged on the right; scale bar, 20 μm. CD34, white; CD206, red; GFP, green; and DAPI, blue.(G) Number of CFU-C per 5×10^3^ CD45^+^ obtained after co-culturing CD206^+^GFP^+^ macrophages in contact with or separate from endothelial cells.(D and G) mean + SEM (n = 4). Student's t test, ^∗^p \< 0.05, ^∗∗^p \< 0.01.

To test the states of GFP^+^CD206^+^ and GFP^+^CD206^−^ cells, chimeric co-cultures of OP9-DL1 stromal cells with cells sorted from *MacGreen* E10.5 AGMs were established and harvested after 1 week, and CD45^+^ cells were examined for HPC activity ([Figure 6](#fig6){ref-type="fig"}D). Both CD206^−^ and CD206^+^ OP9-DL1 co-cultures yielded equivalent numbers of CD45^+^ cells (not shown), and although the CD206^−^ cell co-cultures produced all types of CFU-C, none were produced by the CD206^+^ co-cultures ([Figure 6](#fig6){ref-type="fig"}D, left bars). Thus, CD206^−^ cells are a mixed population of progenitors and macrophages, and the CD206^+^ cells are fully mature macrophages (now defined as AGM-associated macrophages, AGM-aMs).

Spatial localization of AGM-aMs and CD206^−^GFP^+^ cells in E10.5 *MacGreen* AGM and non-AGM trunk regions was quantitatively assessed ([Figure 6](#fig6){ref-type="fig"}E). CD206^−^GFP^+^ cells were found in equal numbers/μm^2^ in the non-AGM and AGM trunk regions and similar numbers of AGM-aMs/μm^2^ were found in the non-AGM trunk region. However, the AGM contained significantly higher numbers of AGM-aMs/μm^2^ (2.5-fold more). Moreover, some were engaged with aortic cells ([Figure 6](#fig6){ref-type="fig"}F), suggesting that AGM-aMs play a role in AGM HS/PC generation through interaction with nascent and emerging IAHCs.

AGM-Associated CD206^+^ Macrophages Enhance Endothelial-to-Hematopoietic Transition {#sec2.8}
-----------------------------------------------------------------------------------

The influence of AGM-aMs and CD206^−^GFP^+^ cells on the hemogenic activity of E10.5 AGM endothelial cells (ECs, CD31^+^CD45^−^CD41^−^) was tested in chimeric co-cultures on OP9-DL1 cells ([Figure 6](#fig6){ref-type="fig"}D, right bars). Cell combinations included: ECs alone, ECs + CD206^−^GFP^+^, and ECs + AGM-aMs. After 1 week, cells were harvested and 5×10^3^ CD45^+^ cells were assayed for HPC activity. ECs alone yielded 203 ± 25 CFU-C. ECs + CD206^−^GFP^+^ cells yielded 311 ± 17 CFU-C (sum of EC-generated CFU-C \[203 ± 25\] plus CD206^−^GFP^+^-cell-generated CFU-C,106 ± 11) ([Figure 6](#fig6){ref-type="fig"}D, left bar). In contrast, ECs + AGM-aMs yielded 366 ± 13 CFU-C. As no CFU-Cs were generated by AGM-aMs in the absence of ECs ([Figure 6](#fig6){ref-type="fig"}D, left bar), the presence of AGM-aMs increased the CFU-C output of ECs by 56%. Moreover, a significant increase in CFU-M and CFU-GEMM was found in ECs + AGM-aMs compared to ECs alone ([Figure 6](#fig6){ref-type="fig"}D), indicating an inductive cooperation between AGM-aM and ECs in the generation of HPCs. To examine whether direct AGM-aM and EC interactions were required, we established transwell cultures. After 7 days, the same induced CFU-C output of ECs + AGM-aMs was observed in non-contact transwell conditions as seen in contact conditions ([Figure 6](#fig6){ref-type="fig"}G), suggesting that in prolonged cultures (as opposed to ≤3 h *in vivo* contact; [Figure 4](#fig4){ref-type="fig"}), the non-contact output is likely a result of soluble factor accumulation in the medium (see [Discussion](#sec3){ref-type="sec"}).

AGM-aMs Are Inflammatory and Transcriptionally Distinct from Macrophage Progenitors {#sec2.9}
-----------------------------------------------------------------------------------

RNA-sequencing datasets of *MacGreen* AGM GFP^+^CD206^+^ and GFP^+^CD206^−^ populations were compared. Unsupervised principal component analysis (PCA) ([Figure 7](#fig7){ref-type="fig"}A) showed AGM-aMs and GFP^+^CD206^−^ cells in two distinct clusters. Differentially expressed gene (DEG) analysis identified 1,265 genes (of 21,911) significantly altered with adjusted p value (false discovery rate, FDR) \<0.05 in AGM-aMs compared to GFP^+^CD206^−^ cells ([Table S2](#mmc3){ref-type="supplementary-material"}). Hierarchical clustering of the top 50 DEGs ([Figure 7](#fig7){ref-type="fig"}B) showed two distinct expression patterns ([Table S3](#mmc4){ref-type="supplementary-material"}). Among 320 genes (log~2~FC1.5/−1.5, FDR ≤ 0.05), 147 were upregulated in AGM-aMs (log~2~FC ≥ 1.5, FDR ≤ 0.05) and showed a dominant inflammatory signature with a specific expression of *Ccl24*, *Ccl9*, *Igf1*, *Tnf*, *Bmp2*, *Pf4*, *Cxcl3*, *Gas6*, *Ccl12*, *Ccl7*, *Ccl2*, and *Il18* ([Figure 7](#fig7){ref-type="fig"}C). Validation of pro-inflammatory gene expression by qRT-PCR ([Figure 7](#fig7){ref-type="fig"}D) confirmed the upregulation of *Tnf*, *Ccl24*, *Ccl9*, *Igf1*, *Bmp2*, *Pf4*, *Ccl2*, and *Ccl7* in AGM-aMs and, thus, AGM-aMs contribute to the pro-inflammatory microenvironment of the AGM.Figure 7Transcriptomic Differences between CD206^−^ and CD206^+^ AGM Cells(A) Principal component analysis (PCA) on all expressed genes in GFP^+^CD206^+^ (green) and GFP^+^CD206^−^ cells (purple) (n = 3, 4 AGMs/experiment).(B--E) Heatmap calculated from the regularized log transformation counts of (B) the top 50 most variable genes, (C) cytokines, and (E) proteinases differentially expressed in GFP^+^CD206^+^ (green) and GFP^+^CD206^−^ (purple) AGM populations. Samples are clustered using average linkage and Pearson correlation. Samples are vertical and genes horizontal; red = upregulated and blue = downregulated genes. Semi-quantitative RT-PCR (mean + SEM) of (D) inflammatory factors (n = 5, 3--4 AGM/experiment) and (F) *Mmp9* (left) and *Mmp13* (right) (n = 5) in E10.5 *MacGreen* GFP^+^CD206^−^ and GFP^+^CD206^+^ cells. (D) Expression in CD206^+^ macrophages normalized over CD206^−^ cells (horizontal line).(F) Expression in CD206^+^ macrophages (gray) normalized over CD206^−^ cells (white).(D and F) Student's t test, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See [Tables S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}.

In addition, the relative expression of *Ifnα*, *Ifnγ*, and *Il1β* (previously reported to affect HS/PC generation in mouse and zebrafish embryos; [@bib38]) and *Mmp9* and *Mmp13* (metalloproteinases involved in extracellular matrix \[ECM\] degradation and aortic HS/PC mobilization in zebrafish embryos; [@bib70]) was tested in AGM-aMs and GFP^+^CD206^−^ cells. No upregulated expression of the cytokines was found in AGM-aM compared to CD206^−^ cells ([Figure 7](#fig7){ref-type="fig"}D), and a mixed "metalloproteinase signature" was found in both fractions ([Figure 7](#fig7){ref-type="fig"}E). However, *Mmp9* and *Mmp13* were significantly upregulated in AGM-aMs, as revealed by qRT-PCR ([Figure 7](#fig7){ref-type="fig"}F). Together, these data reveal that AGM-associated (CD206^+^) macrophages play a positive role in the generation and/or maturation of HPCs and HSCs and may assist in ECM degradation.

Discussion {#sec3}
==========

We have shown that macrophages play a positive role in HSC generation. They are the most abundant innate immune cell type present in the AGM microenvironment prior to HSC generation and are pro-inflammatory. Macrophage progenitors generated in early waves of hematogenesis in the YS ([@bib3], [@bib53]) are recruited through the Cx3cr1 signaling axis to the AGM, where they mature, express CD206, and dynamically interact with nascent and emerging aortic hematopoietic cells to influence AGM HS/PC production.

Phenotypic characterization of CD45^+^ hematopoietic cell types in the AGM by CyTOF analysis for 21 hematopoietic lineage markers revealed little phenotypic heterogeneity. Of 7 clusters identified in tSNE and heatmap analyses, \>83% of cells were phenotypic macrophages and macrophage progenitors. Whether these cells represent progenitors previously described, such as pre-macrophages ([@bib65]) or EMPs ([@bib21], [@bib53]) is uncertain. The CyTOF profiles of CD45^+^ macrophage and progenitors (clusters 5 and 6) showed a high degree of similarity between the AGM and YS. The only detectable difference was the expression of c-Kit by YS CD11b^+^F4/80^−^CD206^−^ cells (cluster 5), thus suggesting that heterogeneity or plasticity in macrophages in specific embryonic hematopoietic tissues is due to local microenvironment and/or differentiation state.

\>14% of AGM CD45^+^ cells (clusters 9 and 11) were phenotypic multipotent HPCs. These two clusters were found in the YS at a similar frequency and at a much lower frequency in the spleen with some marker variation. CD41 (embryonic progenitor and mature megakaryocytic marker) and CD43 (adult pan-leukocyte marker except resting B cells) were expressed by these cells in all three tissues. Cluster 9 cells co-expressing B220 and F4/80 were likely to be bi-potent macrophage B cell progenitors and functionally defined AGM myeloid-B lymphoid progenitors previously reported ([@bib5], [@bib24], [@bib32]). Cluster 11 cells expressing CD11c, B220, CD3, and F4/80 were likely multipotent cells with innate immune fate for innate lymphoid cells (ILCs) and dendritic cells. Whether these embryonic cells are functionally similar to adult cells has yet to be established.

All major AGM and YS cell clusters (5, 6, 9, 11) highly expressed the MerTK macrophage marker, verifying that macrophages are the dominant AGM and YS hematopoietic cell type. In contrast, only rare spleen clusters (2, 5, 6) expressed MerTK. Low expression of NKp46 was also found in most of these clusters. In the adult, NKp46 is a marker for natural killer (NK) cells alongside NK1.1. However, no CD45^+^ cells in the AGM, YS, or spleen were NK1.1^+^. Because it is known that NK1.1^+^ spleen cells are at low frequency and difficult to detect, it is as yet uncertain whether NK cells are present in embryonic tissues and/or whether the NKp46 marker is expressed by other non-NK-cell lineages. Similarly, no mature CD19^+^ B cells were found in the AGM or YS. Although neutrophils and neutrophil progenitors make up about 10% of the spleen CD45^+^ cell population (clusters 1 and 2), no cluster 1 and rare cluster 2 cells were found in the AGM and YS. Thus, the AGM and YS show a bias towards macrophages and progenitor cells, and CyTOF analysis with additional markers should aid in determining the heterogeneity within the embryonic progenitor populations.

As detected by fate mapping ([@bib25]), EMPs migrate from the YS to the caudal half of the mouse embryo between E8.5 and E9. We found that these early generated YS progenitors appear in the AGM by E9 already expressing the CD45 surface marker, but the CD11b and F4/80 mature macrophage markers were expressed only after arrival in the AGM. Macrophages accumulated in the AGM and were found to dynamically interact with nascent and emerging IAHCs. We confirmed that macrophage progenitor appearance in the AGM was, at least in part, Cx3cr1 mediated ([@bib43]). However, since one-third of the total percentage of AGM macrophages is still detectable in *Cx3cr1*^−/−^ mice, we suggest that other chemokines and chemokine receptors such as Cxcl12 and Cxcr4 may be involved.

Vital time-lapse imaging revealed the rapid interstitial movement of macrophages in and around the E10.5 aorta. We observed Csf1r^+^ macrophages entering into the aortic lumen from the surrounding mesenchymal tissue of the AGM. This intravasation was in contrast with a recent report that YS macrophage progenitors colonize embryonic tissues through the circulation (extravasation) ([@bib65]). Moreover, we showed that macrophages dynamically interacted with aortic CD31^+^c-Kit^+^ cluster cells. In some cases, a macrophage underwent cell division and the daughter cells interacted with adjacent or nearby aortic CD31^+^c-Kit^+^ cluster cells. The cell-cell interactions and possible regulatory cross-talk occurring transiently over a few short hours of developmental time (≤3 h) suggests a role(s) for macrophages in the process of HS/PC generation. The AGM HSC-generative microenvironment is present between E10 and E12, a time when the mouse embryo is undergoing rapid growth and remodeling ([@bib75]). Thus, we propose that direct contact of AGM-aMs with EC is needed *in vivo*, whereas AGM-aMs can regulate HS/PC generation in non-contact conditions *in vitro* through soluble signals to EC over many days.

The depletion of AGM macrophages with clodronate-liposomes and Csf1r inhibitor BLZ945 demonstrated that macrophages are indeed important for the production of HSCs. Others have reported that these treatments specifically deplete phagocytic cells *in vivo* ([@bib56], [@bib72]). When AGM explants were treated *in vitro* for 3 days, both the clodronate-liposome and the BLZ945 treatment decreased the percentage of viable macrophages without affecting the overall viability of other AGM cells. The BLZ945 concentration normally used in cell cultures (0.67 μM) was insufficient to eliminate macrophages, likely due to the 3D mass of AGM explants. Depletion (∼60%) was achieved with increased BLZ945 concentration but was still less effective than that mediated by clodronate liposomes (77%). These complementary methods revealed a direct correlation between the reduced macrophage percentages and the decreased number of multipotent HPC CFU-C and lymphoid progenitors compared to control explants. Importantly, the *in vivo* transplantation of clodronate-liposome- and BLZ945-treated AGM cells showed no or little donor-derived hematopoietic repopulation of adult irradiated mice. Despite reports that HSCs are Csf1r expressing, the fact that clodronate-liposome treatment eliminates macrophages and affects both HPC and HSC output of AGM explants strongly supports an active role for macrophages in the AGM HS/PC generative microenvironment.

Many groups over the years have attempted to develop macrophage-deficient mouse models. Pu.1-transcription-factor-deficient mice have no detectable embryonic macrophages, and depending on the deletion strategy, such mice die either by E18 ([@bib61]) or within 48 h from birth ([@bib44]). However, it is unknown whether *Pu*.*1*^−/−^ AGM contains any YS-derived macrophages or AGM-aMs. Similarly, it is not known whether AGM-aMs are present in Csf1-deficient mice (*op*/*op*), which exhibit a general impairment in normal, steady-state hematopoiesis ([@bib73]). Only a small percentage (1%) of mature macrophages remain in *op*/*op* mice, and such mice appear to correct the hematopoietic defects as they age ([@bib2]). With further characterization, these and newly developed models may be useful in establishing more complex chimeric cultures for studies of AGM HSC generation.

At least two types of myeloid populations exist in the AGM: macrophages expressing CD206 (mannose receptor) and CD206^−^ cells, which are a mixed population of macrophages and progenitors. CD206^+^ macrophages contain more vacuoles than the CD206^−^ cells and are more frequent in the AGM region compared to the rest of the embryo. The CD206 mannose receptor is a C-type lectin that functions in endocytosis and phagocytosis, playing an important role in immune homeostasis ([@bib68]). It is a marker of terminally differentiated macrophages in human ([@bib47]) and mouse embryonic macrophages by E10 ([@bib66]). Mice deleted for the mannose receptor show major problems in the clearance of mannose-expressing proteins ([@bib36]). The lack of fetal lethality in germline-deleted mice suggests that it does not affect the embryonic generation of the adult hematopoietic system and therefore serves only as a marker of AGM-aMs.

CD206 expression is generally accepted as an indicator of anti-inflammatory or "M2" macrophages in the adult mouse ([@bib42], [@bib59]). We found that AGM CD206^+^ macrophages expressed a pro-inflammatory signature. Of the pro-inflammatory molecules expressed by AGM-aMs, TNF-α is a modulator of HS/PC formation in zebrafish and mouse embryos ([@bib18]); Ccl24 (Ccr3 ligand) is upregulated in adult macrophages in TNF-α-rich environments and recruits eosinophils during asthma and allergic reactions ([@bib35]); Ccl9 (macrophage inflammatory protein 1-γ or Ccr1 ligand) correlates with leukocyte recruitment in adult mice ([@bib51]); Igf1 (insulin-like growth factor 1) participates in immune-metabolic cross-talk in stress conditions ([@bib64]) and promotes embryo and adult erythropoiesis ([@bib31], [@bib76]); Bmp2 (bone morphogenic protein 2) is secreted by pro- and anti-inflammatory macrophages ([@bib15]) and modulates human HSC proliferation *in vitro* ([@bib4]); platelet factor 4 (Pf4, Cxcl4) attracts monocytes and neutrophils in inflammatory responses, supports hematopoietic cell survival, promotes macrophage maturation, and is expressed by HSCs in the mouse embryo ([@bib7]); and Ccl2 and Ccl7 recruit leukocytes during inflammatory responses ([@bib1]). AGM-aMs did not express more IFN-γ and IL-1β ([@bib18], [@bib33], [@bib38], [@bib52]; Z.L., unpublished data) than CD206^-^cells suggesting that these cytokines may be produced by either cell subset. It will be noteworthy to examine what specific roles these pro-inflammatory molecules play *in vivo* in the AGM, alone and in combination with each other and factors produced by other microenvironmental cells.

It is important to note that our results on pro-inflammatory AGM-aMs are in contrast with those in zebrafish embryos, where proinflammatory cytokines are produced mainly by neutrophils ([@bib18]). Rare immature neutrophilic band cells were found in our cytospins and are likely to be the minor Ly6G^+^ population seen by CyTOF. These immature cells are not phagocytic. Thus, they would not be eliminated during clodronate-liposome treatment that hence should have resulted in an increase in HSC and HPC numbers, not a decrease. We cannot completely rule out the influence of immature neutrophil band cells on HPCs because, after clodronate-liposome treatment, some HPCs (but no HSCs) were still present in the cultures. In Zebrafish embryos, macrophages have been found to dynamically interact with aortic hematopoietic cells and produce Mmp9 and Mmp13, which degrade the ECM to mobilize the emerging cells ([@bib70]). We too have found expression of these Mmps in mouse AGM-aMs and suggest that these pro-inflammatory macrophages play an additional role to mobilize the aortic hematopoietic clusters of the mouse embryo.

Taken together, our data in the mouse embryo show that AGM-associated macrophages expressing the mannose receptor and pro-inflammatory molecules dynamically interact with nascent and emerging aortic cluster cells to affect HPC and HSC production in the AGM. These AGM-associated macrophages elaborate signals that likely affect processes such as HS/PC fate decisions, HS/PC function, ECM degradation, and/or mobilization of newly generated HS/PC. Our results provide a starting point for approaches with these macrophages to recreate the dynamic *in vivo* developmental microenvironment for the *de novo* production of robust HSCs.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-Mouse CD41 (MWReg30)-143NdFluidigmCat\# 3143009CAnti-Mouse CD45R/B220 (clone RA3-6B2)-144NdFluidigmCat\# 3144011CAnti-Mouse CD43 (clone S11)-146NdFluidigmCat\# 3146009CAnti-Mouse CD19 (clone 6D5)-149SmFluidigmCat\# 3149002CAnti-Mouse CD64 (clone X54-5/7.1)-151EuFluidigmCat\# 3151012CAnti-Mouse CD3e (clone 145-2C11)-152SmFluidigmCat\# 3152004CAnti-Mouse CD16/32 (clone 93)-153EuFluidigmCat\# 3153011CAnti-Mouse F4/80 (clone BM8)-159TbFluidigmCat\# 3159009CAnti-Mouse CD11c (clone N418)-162DyFluidigmCat\# 3162017CAnti-Mouse CD31/PECAM-1 (clone 390)-165HoFluidigmCat\# 3165013CAnti-Mouse Nkp46 (clone 29A1.4)-167ErFluidigmCat\# 3167008CAnti-Mouse CD206/MMR (clone C068C2)-169TmFluidigmCat\# 3169021CAnti-Mouse NK1.1 (clone PK136)-170ErFluidigmCat\# 3170002CAnti-Mouse CD11b (clone M1/70 )-172YbFluidigmCat\# 3172012CAnti-Mouse CD117/c-kit (clone 2B8)-173YbFluidigmCat\# 3173004CAnti-Mouse I-A/I-E (clone M5/144)-174YbFluidigmCat\# 3174003CAnti-Mouse FceR1a (clone MAR-1)-176YbFluidigmCat\# 3176006CFITC anti-Mouse/human CD45R/B220 (clone RA3-6B2)BioLegendCat\# 103205; RRID: [AB_312990](nif-antibody:AB_312990){#intref0010}AF647 anti-Mouse CD192 (CCR2) (clone SA203G11)BioLegendCat\# 150603; RRID: [AB_2566139](nif-antibody:AB_2566139){#intref0015}PE-Cy7 anti-Mouse CD193 (CCR3) (clone J073E5)BioLegendCat\# 144513; RRID: [AB_2565739](nif-antibody:AB_2565739){#intref0020}PE anti-Mouse CD195 (CCR5) (clone HM-CCR5)BioLegendCat\# 107005; RRID: [AB_313300](nif-antibody:AB_313300){#intref0025}BV421 anti-Mouse CD197 (CCR7) (clone 4B12)BioLegendCat\# 120119; RRID: [AB_10897811](nif-antibody:AB_10897811){#intref0030}APC/Cy7 anti-Mouse/human CD11b (Mac1) (clone M1/70)BioLegendCat\# 101226; RRID: [AB_830642](nif-antibody:AB_830642){#intref0035}APC anti-Mouse CD206 (mannose receptor) (clone C068C2)BioLegendCat\# 141707; RRID: [AB_10896057](nif-antibody:AB_10896057){#intref0040}PE anti-mouse CD3 (clone 17A2)BioLegendCat\# 100205; RRID: [AB_312662](nif-antibody:AB_312662){#intref0045}Alexa Fluor 647 anti-Mouse CD31 (clone MEC13.3)BioLegendCat\# 102516; RRID: [AB_2161029](nif-antibody:AB_2161029){#intref0050}BV605 anti-Mouse CD31 (clone 390)BioLegendCat\# 102427; RRID: [AB_2563982](nif-antibody:AB_2563982){#intref0055}Anti-Mouse CD34 biotin (clone RAM34)eBioscienceCat\# 13-0341-82PE Rat anti-Mouse CD45 (clone 30-F11)BD BiosciencesCat\# 553081; RRID: [AB_394611](nif-antibody:AB_394611){#intref0060}BV650 anti-Mouse CD45 (clone 30-F11)BD HorizonCat\# 563410; RRID: [AB_2738189](nif-antibody:AB_2738189){#intref0065}APC anti-Mouse CD45.1 (clone A20)BD BiosciencesCat\# 558701; RRID: [AB_1645214](nif-antibody:AB_1645214){#intref0070}PE anti-Mouse CD45.2 (clone 104)BD BiosciencesCat\# 560695; RRID: [AB_1727493](nif-antibody:AB_1727493){#intref0075}BV421 anti-Mouse CD117 (c-Kit) (clone 2B8)BD BiosciencesCat\# 562609; RRID: [AB_11154585](nif-antibody:AB_11154585){#intref0080}BV650 anti-Mouse CX3CR1 (clone SA011E11)BioLegendCat\# 149033; RRID: [AB_2565999](nif-antibody:AB_2565999){#intref0085}PerCP-Cy5.5 anti-Mouse CD182 (CXCR2) (clone SA045E1)BioLegendCat\# 149605; RRID: [AB_2565564](nif-antibody:AB_2565564){#intref0090}PE Dazzle594 anti-Mouse CD184 (CXCR4) (clone L276F12)BioLegendCat\# 146513; RRID: [AB_2563682](nif-antibody:AB_2563682){#intref0095}PE-Cy5 anti-Mouse F4/80 (clone BM8)eBioscienceCat\# 15-4801-80PerCP-Cy 5.5 anti-Mouse Flk-1 (clone AVAS12α1)BD PharmingenCat\# 560681; RRID: [AB_1727524](nif-antibody:AB_1727524){#intref0100}Anti-GFPMBLCat\# 598; RRID: [AB_591819](nif-antibody:AB_591819){#intref0105}BV421 anti-Mouse I-A/I-E (clone M5/114.15.2)BioLegendCat\# 107631; RRID: [AB_10900075](nif-antibody:AB_10900075){#intref0110}PE-CF594 anti-Mouse Ly-6C (clone AL-21)BD HorizonCat\# 562728; RRID: [AB_2737749](nif-antibody:AB_2737749){#intref0115}AF700 anti-Mouse Ly-6G (clone 1A8)BD BiosciencesCat\# 561236; RRID: [AB_10611860](nif-antibody:AB_10611860){#intref0120}PE Cy7 anti-Mouse MerTK (clone DS5MMER)eBioscienceCat\# 25-5751-80PE anti-Mouse CD202b (Tie2/Tek) (clone TEK4)eBioscienceCat\# 12-5987Purified anti-mouse MerTK (clone DS5MMER)eBioscienceCat\# 14-5751-82Purified anti-mouse Ly6C (MaxPar ready) (clone HK1.4)BioLegendCat\# 128039; RRID: [AB_2563783](nif-antibody:AB_2563783){#intref0125}Purified anti-mouse Ly6G (MaxPar ready) (clone 1A8)BioLegendCat\# 127637; RRID: [AB_2563784](nif-antibody:AB_2563784){#intref0130}Purified anti-mouse Siglec F (clone 1RNM44N)eBioscienceCat\# 14-1702-82**Chemicals, Peptides, and Recombinant Proteins**Collagenase from Clostridium histolyticumSigma-AldrichCat\# C0130; Lot\# 02M1425V**Critical Commercial Assays**RNeasy micro kitQiagenCat\# 74004**Deposited Data**RNA-seqThis paperGSE130579**Experimental Models: Cell Lines**Mouse: OP9-DL1[@bib62]Obtained by Prof. Nancy Speck with permission from Zuniga-PlufckerMouse: OP9[http://www.lgcstandards-atcc.org/Search_Results.aspx?dsNav=Ntk:PrimarySearch%7cOP9%7c3%7c,Ny:True,Ro:0,N:1000552&searchTerms=OP9&geo_country=gb&redir=1](http://www.lgcstandards-atcc.org/Search_Results.aspx?dsNav=Ntk:PrimarySearch%257cOP9%257c3%257c,Ny:True,Ro:0,N:1000552%26searchTerms=OP9%26geo_country=gb%26redir=1){#intref0135}**Experimental Models: Organisms/Strains**Mouse: B6.Cg-Tg(Csf1r-EGFP)1Hume/J (also known as MacGreen)The Jackson Laboratory<https://www.jax.org/strain/018549>Mouse: B6.129P2(Cg)-*Cx3cr1*^tm1Litt^/J (also known as CX3CR1-GFP)The Jackson Laboratory<https://www.jax.org/strain/005582>Mouse: B6.Cg-Tg(Ly6a-EGFP)G5Dzk/JThe Jackson Laboratory<https://www.jax.org/strain/012643>Mouse: B6.SJL-*Ptprc*^a^*Pepc*^b^/BoyCrl (also known as Ly5.1)Charles River<https://www.criver.com/products-services/find-model/ly51-mouse?region=3671>**Oligonucleotides**See [Table S5](#mmc6){ref-type="supplementary-material"} for the list of primers**Software and Algorithms**FastQCFastQC: a quality control application for high throughput sequence data<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>STAR (2.3)[@bib13]; STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15--21<https://github.com/alexdobin/STAR>Subread-FeatureCounts (1.5.2)[@bib39]; FeatureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics, 30(7):923-30<http://subread.sourceforge.net/>HiSat (2.0.4)<https://ccb.jhu.edu/software/hisat2/index.shtml>Prism Version 5GraphPad<http://www.graphpad.com/scientific-software/prism>BD Facs Diva version 8BD Biosciences<http://www.bdbiosciences.com/en-us>Image JNIH<https://imagej.nih.gov/ij/>Slidebook 63i<https://www.intelligent-imaging.com/slidebook>FlowJo Version 8.7 and 10.1r5Tree Star, Inc<https://www.flowjo.com/solutions/flowjo/downloads/previous-versions>MATLAB Version 2013bN/AFlowSOMCytobank, Inc<https://premium.cytobank.org/cytobank/>**Other**R coding for CyTOF analysisThis paper<https://github.com/markrobinsonuzh/samanta_cytof_analysis_code>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Elaine Dzierzak (<elaine.dzierzak@ed.ac.uk>).

Experimental Model and Subject Details {#sec4.5}
--------------------------------------

All mice were housed and bred in animal facilities at the University of Edinburgh, in compliance with the Home Office regulations. All procedures with animals were conducted by a Home Office UK Project License (PPL 70/8076) and approved by the University of Edinburgh Ethical Review Committee.

Method Details {#sec4.3}
--------------

### Mouse and embryo generation {#sec4.3.1}

Wild type C57BL/6 from animal facility of the University of Edinburgh, *MacGreen (*B6.Cg-Tg(Csf1r-EGFP)1Hume/J) ([@bib60]), *Cx3cr1-GFP* (B6.129P2(Cg)-*Cx3cr1*^*tm1Litt*^/J )([@bib30]) and *Ly6aGFP* (B6.Cg-Tg(Ly6a-EGFP)G5Dzk/J) ([@bib12]) mice were used for timed mating. Embryos were generated from *MacGreen* (mixed background backcrossed six times into C57BL/6HsdJOla) and *Ly6aGFP* (C57BL/6HsdJOla background) males (two to eight months old) crossed with wild type female mice (two to six months old) and *Cx3cr1*^*gfp/wt*^ males (two to eight months old, mixed background backcrossed five times into C57BL/6HsdJOla) crossed with *Cx3cr1*^*gfp/wt*^ females (two to six months old). Accurate embryo staging was done by somite pair counts. Ly5.1 mice (B6.SJL-*Ptprc*^*a*^*Pepc*^*b*^/BoyCrl, two to four months old) were used as recipients of transplantation experiments.

### Mass cytometry (CyTOF) {#sec4.3.2}

Mass cytometry antibodies were either labeled in-house by using antibody-labeling kits (Fluidigm, California, USA) or purchased (Fluidigm). Antibodies were individually titrated and optimized prior to use. Six palladium metal isotopes were used for live cell barcoding of samples with CD45 ([@bib46]), while keeping CD45-89Y as a common channel to clearly identify cells expressing varying degrees of CD45. Briefly, individual samples from YS, AGM and adult C57BL/6 mouse spleens were incubated with respective CD45-Pd + antibodies in PBS for 30min at room temperature, washed twice with FACS buffer (PBS supplemented with 0.5% BSA), and then pooled into one sample. This was followed by incubation of samples with the cocktail of primary panel antibodies (SuppTable1 and KRT) for 20 min at room temperature and washing with FACS buffer. After washing, samples were incubated with intercalating solution (Iridium in MaxPar Fix/Perm buffer (both Fluidigm)) overnight at 4^o^ C. Prior to acquisition, the samples were washed twice with MilliQ water. Barcoded composite samples were acquired on a Helios mass cytometer (Fluidigm). Quality control and tuning processes on the Helios were performed on a daily basis before acquisition. Data from different days and across acquisition time was normalized by adding five-element beads to the sample immediately before acquisition and using the MATLAB-based normalization software (Version 2013b) ([@bib19]).

### Mass cytometry statistical analysis {#sec4.3.3}

Live cells were exported by manual gating on Event_length, DNA (191Ir and 193Ir), CD45-89Y, and live cells (198Pt) using FlowJo software (Version10.1r5, Tree Star) ([@bib34]). For further analysis, we used our customized R workflow ([@bib50]). All analyses on CyTOF data were performed after arcsinh (with base equal to 5) transformation of marker expression. In brief, pre-processing of the raw data was followed by dimensionality reduction and visualization by t-Distributed Stochastic Neighbor Embedding (t-SNE) with parameters as listed in the figure legends, clustering with FlowSOM into initial 100 nodes ([@bib71]), followed by expert-guided manual metaclustering.

### Whole-mount Images {#sec4.3.4}

*MacGreen* embryos were fixed in 2% PFA-PBS for 20min and dehydrated in 50% methanol in PBS for 10 min followed by 100% methanol for 2x10min. The body wall was trimmed on both sides of the embryo, exposing the AGM for immunochemistry. Embryos were then rehydrated in 50% methanol in PBS (Sigma-Aldrich, Missouri, USA) for 10 min following by PBS and incubated overnight at 4°C with rabbit anti-GFP (1:1000; MBL International, Massachussetts, USA) and rat anti-c-Kit (1:500; eBioscience, Thermo Fisher Scientific, Massachussetts, USA). At 4°C, embryos were washed in PBS-MT (PBS supplemented with 1% skim milk (BioRad, California, USA) and 0.4% TritonX-100 (Acros Organics, Thermo Fisher Scientific) for 3x2hr and incubated overnight with anti-rabbit AlexaFluor488 (1:1000; Invitrogen) and anti-rat AlexaFluor647 (1:5000; Invitrogen, Thermo Fisher Scientific), then washed in PBS-MT for 3x2hr and incubated overnight with biotinylated rat anti-CD31 (1:500; BD Biosciences, New Jersey, USA), then washed in PBS-MT for 3x2hr and incubated overnight with Streptavidin AlexaFluor555 (1:500; Invitrogen, Thermo Fisher Scientific). Embryos were then washed in PBS supplemented with 0.4% TritonX-100 (PBST) and mounted in a FastWell (Sigma-Aldrich) for imaging using a Leica SP5 confocal microscope. Using Fiji (ImageJ), a maximum projection image with merged colour channels was generated.

### Tissue Sections {#sec4.3.5}

*MacGreen* embryos were fixed in 2% PFA-PBS for 30 mins and washed in PBS for 10 mins at 4°C. Embryos were then equilibrated in 20% sucrose in PBS for 30 mins at 4°C. Embryos were washed in OCT embedding matrix for frozen sections (CellPath, Thermo Fisher Scientific), using tissue paper to remove remaining sucrose. Each embryo was placed in an individual mould containing OCT and orientated forelimbs exactly above hindlimbs and YS to one side before being quickly frozen on dry ice in absolute ethanol. Frozen OCT blocks were then removed from the mould, wrapped in Parafilm^R^ and stored at -80°C. 10μm sections were taken along the length of the AGM of MacGreen embryos using a Bright OTF5000 cryostat and placed on poly-lysinated glass slides (Thermo Fisher Scientific) 8 sections/slide that were then stored at -20°C. For immunohistochemistry, slides were blocked in 50% Avidin D solution (Vector Laboratories Inc., California, USA) diluted in PBS supplemented with 0.05% Tween20 and 1% bovine serum albumin (BSA) (PBS~block~) and washed in PBST. Slides were incubated for 1hr with rat anti-CD34 (1:200; eBioscience, Thermo Fisher Scientific), rabbit anti-GFP (1:1000; MBL International) and rat anti-CD206 (MR; 1:50; BioLegend, California, USA) diluted in PBS~block~ at RT and washed in PBST, then incubated for 1hr with anti-rabbit AlexaFluor488 (1:1000; Invitrogen, Thermo Fisher Scientific) and Streptavidin Cy3 (1:2500; Jackson ImmunoResearch Laboratories, Pennsylvania, USA)) diluted in PBS~block~ at RT and washed in PBST before 10mins incubation in DAPI (1:1000) diluted in PBS~block~ at RT. Slides were washed and mounted with coverslips using SlowFade Diamond Anti-Fade Mountant (Invitrogen, Thermo Fisher Scientific). Sections were imaged on a Leica SP5 confocal microscope. 10 sections from along the length of the AGM were imaged per embryo. Using Fiji (ImageJ), a maximum projection image of each section with merged colour channels was obtained.

### Time-lapse *ex vivo* imaging {#sec4.3.6}

*MacGreen* embryos were stained by intra-aortic flushing with anti-CD31-AF647 (clone MEC13.3, Biolegend) and anti-c-Kit-BV421 (clone 2B8, BD Biosciences) antibodies and incubated 30min at 4°C in PBS + 10% FBS. The embryos were then transversally thick-sectioned with an automatic tissue chopper into 150μm sections that were embedded in low melting agarose (Sigma-Aldrich) and placed in a chamber ring support (Attofluor cell chamber, Invitrogen, Thermo Fisher Scientific) closed at the bottom with a round glass cover slip (Menzel Gläser, VWR, Pennsylvania, USA). The agarose-embedded sections were then covered with MyeloCult M5300 medium (StemCell Technologies) supplemented with hydrocortisone succinate 10^−6^M (Sigma-Aldrich) and mIL3 20ng/ml (Peprotech, New Jersey, USA). Overnight imaging was performed either on a CSU-W1 Spinning disk confocal ([Videos S1](#mmc7){ref-type="supplementary-material"} and [S2](#mmc8){ref-type="supplementary-material"}) or a Andor spinning disk (20x objective) and analyzed with the integrated software with a 10-minute interval for a total of 14--16 h, step size 3 μm and a z-range of 20--40 steps. The samples were maintained at 37°C. Videos were analyzed with Slidebook software (3i, Colorado, USA). Lateral drifting of the section imaged in the movie 2 was corrected with Huygens software.

### AGM explant cultures {#sec4.3.7}

AGM from E10.5 MacGreen embryos (34-39sp) were dissected and cultured for 72 h at 37° C with 5% CO~2~ at the air-liquid interface in a six well plate on a metal mesh covered with durapore membrane filter paper (Millipore, Massachusetts, USA). The MyeloCult M5300 medium (StemCell Technologies) used was supplemented with hydrocortisone succinate 10^−6^M (Sigma-Aldrich).

### CFU-C assay and stem cell transplantation {#sec4.3.8}

Cells from AGM or AGM explants were digested at 37°C in 0.125% type 1 collagenase (C0130, Sigma- Aldrich) for 45 min and then cultured in Methylcellulose (M3434; Stem Cell Technologies, Canada) at 37° C with 5% CO~2~. Colonies were counted and scored after 10 days.

AGM explant cells were prepared into single cell suspensions, as described above, and injected intravenously into irradiated Ly5.1 recipients two doses of 4.5 Gy of γ-irradiation). After 4 and 16 weeks, peripheral blood was taken for CD45.1- and CD45.2- flow cytometric analysis. Recipient mice are considered reconstituted when ≥5% of cells are donor-derived.

### OP9/OP9-DL1 co-culture system {#sec4.3.9}

AGM derived endothelial cells (CD31^+^CD45^−^CD41^−^) and macrophages (CD206^+^ and CD206^−^) were co-cultured with OP9-DL1 cells at 37° C with 5% CO~2~ in cytokine containing αMEM (SCF100ng/ml, IL3 100ng/ml and Flt3-ligand 100ng/ml, Peprotech). After seven days of co-culture, CD45^+^ cells were FACS sorted and plated in methylcellulose (M3434; Stem Cell Technologies). Colonies were counted and scored after 10 days. For the transwell experiment, Corning HST Transwell (Thermo Fisher Scientific) with 3μM pores were used to separate the endothelial cells (bottom of the well) from macrophages. CD206^+^ macrophages were put either in contact with endothelial cells or at the top of the transwell filter. After 7 days of co-culture, at 37° C with 5% CO~2~, CD45^+^ cells derived from the endothelial cells (bottom of the transwell) were FACS sorted and plated in methylcellulose. Colonies were counted and scored after 10 days. For the lymphoid potential progenitor assay, AGM explants were digested and single cells plated on OP9 stromal cells in αMEM with the addition of IL7 20ng/ml and Flt3 20ng/ml. Medium was replaced every 3 days and the cells were plated on fresh OP9 every 7 days. Flow cytometric analysis for macrophage and B cell markers was performed after 10 days of co-culture.

### BLZ945 and Clodronate-liposome treatment {#sec4.3.10}

AGM explants were pre-incubated for 2 h at 37°C in MyeloCult M5300 medium + BLZ945 (0.67, 6.7 or 67 μM) or clodronate-liposomes (1:5 dilution) and their controls, DMSO and PBS-liposomes, respectively. Then the explants were recovered from the wells with curved forceps and placed for 72 h on the metal mesh + filter paper (see above for details). The treatments were added to the explant medium at time zero and 48 h later.

### Flow analysis and sorting {#sec4.3.11}

Cells from AGM, YS, culture systems and hematopoietic organs of adult mice were blocked in PBS+10%FBS and then stained with antibodies (SupTable4) for 30 min on ice. Excess of antibodies was washed away with PBS/FBS before flow cytometry analysis. Sorted cells were collected in 50% PBS/FBS for functional analyses or in Qiagen RLT lysis buffer for RNA extraction. Cytometry was performed on LSR Fortessa, Aria॥ and Fusion (BD Bioscience).

### Gene Expression Analysis {#sec4.3.12}

RNA from sorted cells was extracted by using RNeasy Micro Kit (Qiagen, Germany). cDNAs were generated using oligdT primers and SuperScript III Reverse Transcriptase (Invitrogen Thermo Fisher Scientific) according to manufacturer instructions. RT-PCR were performed by using Fast SYBR Green Master Mix (Thermo Fisher Scientific) on an ABI 7900 machine (Applied Biosystems, California, USA). See [Table S5](#mmc6){ref-type="supplementary-material"} for the list of the primers used.

### RNA-seq {#sec4.3.13}

RNA from sorted cells (*MacGreen* GFP^+^CD206^−^ and GFP^+^CD206^−^) was extracted by using RNeasy Micro Kit (Qiagen) and the RNASeq samples were prepped according to the Smart-seq2 method ([@bib55]). The samples were then sequenced according to the Illumina TruSeq Rapid v2 protocol on the HiSeq2500 machine with a single read 51 bp and dual 9+9bp index and mapped against the requested reference using HiSat2 (version 2.0.4). Gene expression values were called using htseq-count (version 0.6.1).

### Sequencing alignment and Quantification {#sec4.3.14}

Fastq files of 51bp single-end reads were quality controlled using FASTQC. Reads were then aligned to the GENCODE M14 mouse reference genome (mm10) using STAR aligner (version 2.3) for Linux Ubuntu, with default options, and ran over 8 threads per sample. For improved accuracy, the exon junction coordinates from the reference annotation were used. Resulting BAM files from different lanes were merged into one sample. Gene quantification on the merged samples was performed using featureCounts from the subRead package.

### Statistical analysis for differentially expressed genes {#sec4.3.15}

All statistical calculations have been performed in R programming language (version 3.2.3). Genes with expression 0 or 1 were filtered out. Differential expression analysis was performed using DESeq2 package to identify significantly differentially expressed genes with controlled False Positive Rate (B&H method) at 5% (FDR ≤ 0.05). Up-regulated genes were selected at a minimum log~2~ fold change of 1.5 and down-regulated genes at a minimum log~2~ fold change of −1.5. Principle component analysis was performed on the regularized log transformed (rlog) expression matrix on all genes. Heatmaps were drawn on the regularized transformed (rlog) expression matrix (*pheatmap* package). Pearson correlation and average linkage were used for hierarchical clustering.

Quantification and Statistical Analysis {#sec4.4}
---------------------------------------

All graphs were generated using GraphPad Prism 5. A one-way Anova with Dunnett post-hoc test was used to compare total macrophages numbers in the AGM to that in the non-AGM region. To compare tissue section cell counts for GFP^+^CD206^−^ and GFP^+^CD206^+^ macrophages across the different regions, a two-way ANOVA with multiple comparisons corrected by a Tukey's range test was used. A one-way ANOVA corrected by Bonferroni's test was used to compare more than 2 groups, whereas the Student's t test was used when the groups to compare were only two. Details of the statistical test used can be found in the figure legends. Significance was defined as p \< 0.05. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Data and Software Availability {#sec4.7}
------------------------------

The accession number for the RNA-seq data reported in this paper is GSE130579.
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Document S1. Figures S1--S6Table S1. List of Antibodies Used for Mass Cytometry Divided by Cell Type, Related to Figure 1The first column shows the name of the antigens recognized by the different antibodies divided by cell type, the second column shows the metal conjugated to the antibodies used, the third column shows the clone, and the distributor is indicated in the fourth column.Table S2. List of the Differentially Expressed Genes in GFP^+^CD206^+^ Macrophages Versus GFP^+^CD206^−^ Cells, Related to Figure 7The row name (first column), gene name (second column), log2 fold change value (third column), p value (fourth column), and adjusted p value (fifth column) are provided for each differentially expressed gene.Table S3. List of 50 Most Differentially Expressed Genes in GFP^+^CD206^+^ Macrophages versus GFP^+^CD206^−^ Cells, Related to Figure 7The row name (first column), gene name (second column), log2 fold change value (third column), p value (fourth column), and adjusted p value (fifth column) are provided for each differentially expressed gene.Table S4. List of Antibodies Used for Flow Cytometry Experiments, Related to Figure 2, Figure 3, Figure 5, and Figure 6The name of the antigen recognized by the antibody and the fluorophore are shown in the first column; the clone and the company are provided in the second and third columns, respectively.Table S5. List of Primer Used for the Validation of the RNA-Sequencing by Real-Time PCR, Related to Figure 7The gene name (first column) and the 5′--3′ sequence (second column) are shown for each primer.Document S2. Article plus Supplemental Information
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